These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29416345)

  • 21. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
    Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma.
    Su Q; Zhu EC; Qu YL; Wang DY; Qu WW; Zhang CG; Wu T; Gao ZH
    J Cancer; 2018; 9(21):3991-3999. PubMed ID: 30410604
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Machine Learning and Blood-Based miRNAs.
    Tang JY; Kouznetsova VL; Kesari S; Tsigelny IF
    Oncology; 2024 Sep; ():1-10. PubMed ID: 39231457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
    Vychytilova-Faltejskova P; Kiss I; Klusova S; Hlavsa J; Prochazka V; Kala Z; Mazanec J; Hausnerova J; Kren L; Hermanova M; Lenz J; Karasek P; Vyzula R; Slaby O
    Diagn Pathol; 2015 Apr; 10():38. PubMed ID: 25908274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.
    Karasek P; Gablo N; Hlavsa J; Kiss I; Vychytilova-Faltejskova P; Hermanova M; Kala Z; Slaby O; Prochazka V
    Cancer Genomics Proteomics; 2018; 15(4):321-327. PubMed ID: 29976637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine enhances OSI-027 cytotoxicity by upregulation of miR-663a in pancreatic ductal adenocarcinoma cells.
    Huang B; Wang J; Chen Q; Qu C; Zhang J; Chen E; Zhang Y; Wang Y; Ni L; Liang T
    Am J Transl Res; 2019; 11(1):473-485. PubMed ID: 30788003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
    Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
    Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
    Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma.
    Suzuki R; Asama H; Waragai Y; Takagi T; Hikichi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Sato Y; Marubashi S; Masamune A; Ohira H
    Oncotarget; 2018 Jan; 9(4):4451-4460. PubMed ID: 29435115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
    Yu Q; Xu C; Yuan W; Wang C; Zhao P; Chen L; Ma J
    Biomed Res Int; 2017; 2017():6495867. PubMed ID: 28466015
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians.
    Giannis D; Moris D; Barbas AS
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating microRNAs as diagnostic biomarkers for pancreatic cancer.
    Le Large TY; Meijer LL; Prado MM; Kazemier G; Frampton AE; Giovannetti E
    Expert Rev Mol Diagn; 2015; 15(12):1525-9. PubMed ID: 26567751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the diagnostic and prognostic value of long non-coding RNA SNHG15 in pancreatic ductal adenocarcinoma.
    Guo XB; Yin HS; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5892-5898. PubMed ID: 30280769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer.
    Yang JY; Sun YW; Liu DJ; Zhang JF; Li J; Hua R
    Am J Cancer Res; 2014; 4(6):663-73. PubMed ID: 25520858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal alterations of miR-1 and miR-214 are associated with clinicopathological features and prognosis of patients with PDAC.
    Cheng Q; Han LH; Zhao HJ; Li H; Li JB
    Oncol Lett; 2017 Oct; 14(4):4605-4612. PubMed ID: 29085459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.